What clinicians say about our courses H-LAPCO_demo_with_Tom_Cecil

  • By miles, this has been one of the most informative meetings I have been to in recent times. My knowledge base and experience in this nebulous field is very limited as the current practice in our MDT is to err on the side of over-diagnosis/over treatment. I look forward to more such visits to the Pelican centre.

  • 'In our view all surgeons should come and see the experts work at Pelican... The bottom line is they’ll save lives as a result.' - Professor Alex Deutsch, Chair of the Yanir Foundation for the Advancement of Colorectal Surgery in Israel

  • 'The whole masterclass was excellent. All was very relevant and interesting. Well organised and well worth attending'

  • 'We are continuing to feel the benefits and refer back to the course' - clinical oncologist

  • 'It changed the way I practice' - radiologist

  • 'TME has transformed my whole surgical life' – surgeon

  • 'I think this really does impact on cancer outcomes' - clinical oncologist

  • 'Very helpful to see the surgery' - radiologist

  • 'Excellent and informative' - nurse

  • 'The only opportunity our team has had to attend anything as a team' – nurse

  • 'An excellent model for disease-specific MDT course' - radiologist

  • 'Fantastic course – good well-thought-out overview of colorectal cancer and current debates'

  • 'Very good speakers who have increased my knowledge in a very interesting, enjoyable and informative way'

  • 'Excellent, relevant course'

  • 'Enjoyable, well-constructed two days with excellent speakers. Networking extremely valuable'

  • 'Good for team building' - clinical oncologist

  • 'It was important for all disciplines to understand each other's roles' - nurse

  • 'An excellent two days, well organised and relevant topics'

  • 'Very stimulating, refreshing and motivating'.

  • 'Good workshop - worth the MDT spending a day out'

  • 'Has led to organising MDT away day to discuss the complex issue further'

  • 'More convinced about the indications for ELAPe Vs inter-sphincteric'

  • 'We are re-considering our usage of neo-adjuvant therapy'

Speakers from recent courses give a brief summary of their talk: